50% of peripheral accesses in oncology are lost before the start of treatment⁴. And, in the case of hospitalized patients, premature loss is reported in 69% of cases³. Recent
"Why do I need to protect myself from something I don't see?" This dialogue is present in the episodes of the dramatic series Chernobyl, produced by HBO and nominated for the Emmy, which portrays
In line with Anvisa (National Health Surveillance Agency) health care-related infection prevention measures package, BMR Medical introduces ivKIT® to the market
The handling of antineoplastic drugs has gained another ally. In addition to being simpler, the OncoSafe® Arisure ™ Closed System transfer device, tested and approved by NIOSH (National